Comparison of efficacy of lignocaine cold spray and shotBlockerin reducing pain during intramuscular injections in childre
Not Applicable
- Registration Number
- CTRI/2023/01/048642
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children age > 1year to <18 year.
Children receiving one injection at a time
Children whose families give consent
Children receiving vaccines only through intramuscular route
Exclusion Criteria
Children receiving DPT containing vaccines
Children receiving vaccines via subcutaneous or intradermal route of administration
Presence of any disease which causes chronic pain
Children with neurodevelopmental disorders
History of fainting during injection
Presence of any skin disease
Families those who didn’t give consent
Infections at the site of injection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of lignocaine cold spray and shotblocker <br/ ><br>in reducing the intramuscular (IM) injection-related pain in <br/ ><br>children.Timepoint: Pain scale assessed at 0 min and at 5 minutes of administration of injection.
- Secondary Outcome Measures
Name Time Method Cost effective <br/ ><br>Easy to use <br/ ><br>Side effectsTimepoint: Child observed for 30 minutes after IM injection for any adverse effects